Current Affairs - Business

The TIME World's Best Companies of 2024 list features Apple at the top position with an impressive overall score of 97.75, recognizing its excellence in the IT, Electronics, Hardware, and Equipment industries. This prestigious ranking highlights the company's significant influence and leadership in the global corporate landscape. Notably, Indian companies have also made a mark, with HCLTech securing the 112th position, followed closely by Infosys at 119th and Wipro at 134th. Other Indian companies, such as Reliance Industries (646th) and Adani Group (736th), also feature on the list, demonstrating India's growing presence in the global corporate arena. The list includes 22 Indian-born enterprises among the 1000 companies recognized worldwide.

EVFY opened its first fast-charging station in Gurgaon, marking a significant step in its expansion plans for the Indian market. Located in Sector 73, this station features a 150 kW fast charger and is designed to support a range of electric vehicles, from two-wheelers to buses. The company's goal is to establish 100 such stations by 2025, reflecting its commitment to catering to the growing demand for electric vehicles in India. This initiative includes future plans for ultra-fast chargers and a dedicated app to enhance user convenience.

The Ministry of Skill Development and Entrepreneurship has partnered with Swiggy to launch a program aimed at enhancing skilling and employment opportunities for Swiggy's delivery partners and restaurant staff. This initiative will provide training through the Skill India Digital Hub (SIDH) and aims to benefit around 2.4 lakh individuals. The collaboration focuses on improving skills in the logistics and retail sectors, contributing to the overall growth and employment prospects within Swiggy's network.

The Adani Group, in partnership with Israel’s Tower Semiconductor, will invest $10 billion in a semiconductor plant in Maharashtra, India. This significant project is part of India's efforts to boost domestic chip production and establish itself as a global hub for semiconductors. The plant aims to produce 40,000 wafers initially, contributing to India's growing semiconductor market, which is projected to reach $63 billion by 2026.

Alembic Pharmaceuticals received approval from the US Food and Drug Administration (USFDA) for its Albendazole Tablets USP (200 mg), a generic version of Impax Laboratories' Albenza. This approval allows Alembic Pharma to market its generic tablets, which are used to treat infections such as parenchymal neurocysticercosis and cystic hydatid disease caused by worm larvae. The approved ANDA (Abbreviated New Drug Application) is therapeutically equivalent to Impax Laboratories' Albenza tablets.